[Recommendations of antimicrobial treatment in patients allergic to beta-lactam antibiotics]

Area of Science:

• Infectious Diseases
• Immunology
• Pharmacology

Background:

• Beta-lactam antibiotics are primary treatments for severe bacterial infections.
• Allergic reactions to beta-lactams, though less common than other adverse drug reactions, significantly increase morbidity, mortality, and healthcare costs.
• Both IgE antibodies and T cells mediate distinct types of hypersensitivity reactions to beta-lactams.

Framework:

• Clinical assessment involving medical history, skin testing, and provocation is essential for diagnosing beta-lactam allergy.
• Management decisions, including avoidance or desensitization, depend on the specific reaction's nature and severity.
• Identification of major and minor antigenic determinants for penicillin aids in understanding allergic mechanisms.

Implementation:

• Guidelines are provided for managing patients with beta-lactam allergies.
• Alternative antibiotics like tigecycline, linezolid, and daptomycin offer effective and safe options.
• Evidence-based recommendations and expert opinions inform the management strategies.

Implications:

• Improved patient outcomes through appropriate management of beta-lactam allergy.
• Reduced healthcare costs associated with adverse drug reactions and prolonged treatments.
• Enhanced understanding of hypersensitivity mechanisms guiding future therapeutic approaches.